MARIA YBANEZ: Open Payments
NPI 1144052804 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $103 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 7 | $233 |
| Amgen Inc. | 10 | $221 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $212 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $145 |
| Medtronic, Inc. | 1 | $110 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: FUROSCIX, REPATHA, LifeVest, Kerendia, VENASEAL, JARDIANCE, FARXIGA, WAINUA.
Industry payments across TX — which companies pay providers there.
